MaxCyte (MXCT) Balance Sheet: Assets & Liabilities

MaxCyte (MXCT) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), MaxCyte reported total assets of $202.51M and total liabilities of $31.02M. Shareholders' equity was $171.49M, down 16.9% from $206.25M a year earlier. Total debt stood at $17.94M against $103.04M in cash and short-term investments, a net cash position of $85.10M. That puts debt-to-equity at 0.10, compared with 0.09 a year earlier.

MaxCyte Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for MaxCyte, Inc. (MXCT) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Mar 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Current Assets
Cash and Cash Equivalents	20.07	27.88	46.51	11.07	47.78	18.76	18.76	15.21	11.25	25.34
Short-Term Investments	82.98	126.60	121.78	216.28	207.26	16.01	16.01	1.50	3.19	0.00
Cash & Short-Term Investments	103.04	154.48	168.29	227.34	255.04	34.76	34.76	16.71	14.44	25.34
Accounts Receivable	3.50	4.68	5.78	13.09	6.88	5.17	5.17	3.24	4.90	3.20
Inventory	7.55	8.91	12.23	8.58	5.20	4.32	4.32	3.70	2.24	1.35
Other Current Assets	4.28	3.61	3.90	3.26	3.31	1.00	1.00	0.80	0.86	0.67
Total Current Assets	118.37	171.68	190.19	252.27	270.43	45.25	45.25	24.45	22.45	30.55
Non-Current Assets
Property, Plant & Equipment (Net)	28.45	30.47	34.75	33.58	13.37	6.49	6.49	5.53	1.82	0.85
Long-Term Investments	52.57	35.78	42.94	0.00	0.00	0.00	-	0.00	0.00	0.00
Intangible Assets	0.65	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00	0.00
Other Non-Current Assets	2.47	1.53	0.39	0.81	0.32	0.03	0.03	0.00	0.00	0.00
Total Non-Current Assets	84.14	67.79	78.08	34.39	13.69	6.53	-	5.53	1.82	0.85
Total Assets	202.51	239.47	268.27	286.65	284.12	51.78	51.78	29.99	24.27	31.40
Current Liabilities
Accounts Payable	1.40	1.36	0.74	0.29	1.82	0.89	0.89	2.09	1.03	4.33
Short-Term Debt	1.46	0.86	0.77	0.16	0.53	0.67	-	0.51	0.00	0.85
Accrued Liabilities	7.81	8.30	11.27	8.27	6.52	-	5.21	-	-	-
Deferred Revenue	3.60	5.25	5.07	6.71	6.75	4.84	4.84	3.19	2.45	2.06
Other Current Liabilities	7.81	8.30	11.27	14.98	6.52	5.21	-	3.55	3.09	-0.85
Total Current Liabilities	14.27	15.78	17.86	15.43	15.62	11.61	11.61	9.34	6.57	7.24
Non-Current Liabilities
Long-Term Debt	16.49	17.17	17.97	15.94	5.15	6.29	4.92	6.70	5.06	4.18
Other Non-Current Liabilities	0.26	0.27	0.28	1.32	0.45	0.65	0.65	0.34	0.36	0.38
Total Non-Current Liabilities	16.75	17.44	18.25	17.26	5.61	6.94	-	7.04	5.41	4.56
Total Liabilities	31.02	33.22	36.11	32.69	21.22	18.55	18.55	16.38	11.99	11.80
Stockholders' Equity
Common Stock	1.07	1.06	1.04	1.02	1.01	0.77	0.77	0.57	0.51	0.51
Retained Earnings	-261.48	-216.85	-175.80	-137.88	-114.30	-95.22	-95.22	-83.41	-70.51	-61.64
Additional Paid-in Capital	431.91	422.05	406.93	390.82	376.19	127.67	-	96.43	82.28	80.73
Shares Outstanding	106.79	105.71	103.96	102.40	101.20	-	-	-	-	-
Total Stockholders' Equity	171.49	206.25	232.17	253.97	262.90	33.23	33.23	13.60	12.28	19.60
Total Liabilities & Equity	202.51	239.47	268.27	286.65	284.12	51.78	-	29.99	24.27	31.40

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About MaxCyte Balance Sheet

How much debt does MaxCyte have?

MaxCyte had total debt of $17.94M as of Dec 31, 2025, against $103.04M in cash and short-term investments. Its debt-to-equity ratio was 0.10. Total debt was $18.03M a year earlier.

What are MaxCyte's total assets?

MaxCyte reported total assets of $202.51M as of Dec 31, 2025, down 15.4% from $239.47M a year earlier. Total liabilities were $31.02M.

What is MaxCyte's shareholders' equity?

MaxCyte's shareholders' equity was $171.49M as of Dec 31, 2025, or about $1.61 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition